Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Sales | 13,676 | 13,160 | 7,674 | 5,333 | 2,534 |
| Cost of Goods | 10,840 | 15,409 | 14,227 | 7,799 | N/A |
| Gross Profit | 2,836 | -2,249 | -6,553 | -2,466 | 2,534 |
| Operating Expenses | 64,658 | 60,733 | 59,865 | 54,314 | 48,936 |
| Operating Income | -60,982 | -62,573 | -66,191 | -55,981 | -46,402 |
| Other Income | 3,490 | 2,128 | 631 | 2 | -1,026 |
| Pre-tax Income | -57,492 | -60,445 | -65,560 | -55,979 | -47,428 |
| Net Income Continuous | -57,492 | -60,445 | -65,560 | -55,979 | -47,428 |
| Net Income | $-57,492 | $-60,445 | $-65,560 | $-55,979 | $-47,428 |
| EPS Basic Total Ops | -0.30 | -0.35 | -0.38 | -0.33 | -0.28 |
| EPS Basic Continuous Ops | -0.31 | -0.35 | -0.38 | -0.33 | -0.28 |
| EPS Diluted Total Ops | -0.30 | -0.35 | -0.38 | -0.33 | -0.28 |
| EPS Diluted Continuous Ops | -0.31 | -0.35 | -0.38 | -0.33 | -0.28 |
| EPS Diluted Before Non-Recurring Items | -0.31 | -0.35 | -0.38 | N/A | N/A |
| EBITDA(a) | $-57,768 | $-59,584 | $-63,405 | $-53,214 | $-44,166 |